New Jobs Follow New Tenant to North Carolina Research Campus

The North Carolina Research Campus announced today at a news
conference that PPD, Inc. (PPD), a global contract research
organization, is opening an office at the campus, which may bring 200
to 300 new jobs. The jobs will be added over a 24-to-36-month period
and will focus on clinical research.

"When I promised three years ago that the NC Research Campus would
attract the greatest scientists and companies in the world to create
cures for our most deadly and debilitating diseases, it was with
companies like PPD in mind," said David H. Murdock, chairman and owner
of Castle & Cooke, Inc. and Dole Food Company, Inc. "The presence of
PPD is only the beginning; the future is bright."

Leaders from the scientific, medical, economic development and
business communities participated in the news conference at the NC
Research Campus to lay out the importance of the new announcement,
including Dr. Andrew Conrad, NC Research Campus´ chief scientific
officer; Norris Tolson, president and CEO of the North Carolina
Biotechnology Center; Carol Lovin, senior vice president of Carolinas
HealthCare System´s Management Company; James McDeavitt, M.D., senior
vice president of education and research for Carolinas Healthcare
Center; Ronnie Bryant, president and CEO of the Charlotte Regional
Partnership; N.C. Senator Fletcher Hartsell, Kannapolis Mayor Bob
Misenheimer, Cabarrus County Commissioner Chairman Jay White and John
Cox, president and CEO of the Cabarrus Regional Chamber of Commerce.

"For a couple of years, I have heard many great things about the
NC Research Campus," said Fred Eshelman, CEO of PPD, based in
Wilmington, N.C. "After meeting with Mr. Murdock and visiting the
campus, I realized this project is a once-in-a lifetime opportunity
where industry and academic scientists can freely collaborate to bring
innovations in scientific research to market, increasing the length
and quality of human life."

For Clyde Higgs, vice president of business development for the NC
Research Campus, PPD´s presence is indicative of a great plan, great
people and a great mission coming together to create a one-of-a-kind
research environment.

"You are beginning to see that buildings aren´t the only thing
rising in Kannapolis," said Higgs. "Having a global contract research
organization like PPD at the research campus continues our mission to
make the NC Research Campus the world´s top scientific community that
will be the home of groundbreaking research and development."

PPD´s expansion of its contract research operations into the
40,000 square foot office space will provide hundreds of jobs for
clinical research associates, clinical project managers and other
medical and scientific personnel to collaborate with pharmaceutical
and biotechnology companies to develop life-saving therapies. PPD will
co-locate with Carolinas Healthcare System in the Medical Office
Building at the NC Research Campus.

As positions become available at the NC Research Campus, staffing
these positions will be a high priority. In response to these job
opportunities, Rowan-Cabarrus Community College is developing a
certificate and degree program for clinical research associates.

In addition to researchers from Duke University, the University of
North Carolina system and the N.C. Community College System, the NC
Research Campus houses operations from companies like Anatomics,
Angiogen, Carolinas Healthcare System and Red Hat.

About the North Carolina Research Campus

Planned as a public-private collaboration, the North Carolina
Research Campus combines the research power of world-renowned
universities and workforce training programs with the know-how of
business. This "dream team" includes David H. Murdock, Duke
University, the University of North Carolina system and the N.C.
Community College System.

Other features of the research campus (www.ncresearchcampus.net)
include:

-- A 350-acre campus that complements North Carolina´s biotech
corridor.

-- An initial 311,000-square-foot building to house the core
laboratory, a state-of-the-art research facility and tenants.
The David H. Murdock Core Laboratory, to be owned by a public
charity created and funded by David Murdock, will feature the
most advanced equipment available in the areas of Molecular
Genomics, Proteomics, Metabolomics, Bioinformatics, and will
include Analytical Chemistry, Animal Imaging, Histochemistry,
Microscopy, and Nuclear Magnetic Resonance laboratories. Many
of the pieces of equipment are the first of their kind in the
world, including the Bruker Biospin 950 MHz Nuclear Magnetic
Resonance spectrometer, the 454 series of DNA sequencers and a
multi-laser source cyclotron.

-- One million square feet of office and laboratory space.

About PPD

PPD is a leading global contract research organization providing
discovery, development and post-approval services as well as compound
partnering programs. Our clients and partners include pharmaceutical,
biotechnology, medical device, academic and government organizations.
With offices in 30 countries and more than 10,200 professionals
worldwide, PPD applies innovative technologies, therapeutic expertise
and a commitment to quality to help its clients and partners maximize
returns on their R&D investments and accelerate the delivery of safe
and effective therapeutics to patients. For more information, visit
our Web site at http://www.ppdi.com.